Lilly: A Collective Impact Approach to Global Partnerships

Primary tabs

Lilly: A Collective Impact Approach to Global Partnerships

tweet me:
Each year, #NCDs claim 12 million lives and $500B in lost productivity. Can the private sector make a greater impact? http://ow.ly/Bl3Vn

Multimedia from this Release

Thursday, September 11, 2014 - 8:30am

CAMPAIGN: Lilly Global Health Programs

CONTENT: Blog

Today's guest blog comes from Lilly's Vice President of Global Health Programs, Evan Lee, M.D.
 
Marcia Conner has a great piece in Fast Company about changing the world. She argues that the best way to effect change is to combine personal responsibility with collective impact, in which people unite behind principles to achieve systemic reform. This struck a chord because it applies to one of the biggest global health challenges today: non-communicable diseases (NCDs) like diabetes and cancer.
 
To set the stage, the UN is driving a high-level initiative to tackle NCDs, which together claim about 12 million lives and cost $500 billion in lost productivity each year. And the World Health Organization (WHO) is coordinating efforts among the many public and private actors scaling up treatment, prevention and R&D efforts.

Read on for more about the progress of WHO and public-private partnerships in the fight against NCDs.

Keywords: Health & Healthcare | Cancer | Eli Lilly and Company | Global Health | Health & Healthcare | Lilly | World Health Organization (WHO) | diabetes | noncommunicable diseases (NCDs)

CAMPAIGN: Lilly Global Health Programs

CONTENT: Blog

parse.ly